Uncovering news
and insights

We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.

black woman holding phone looking up
Featured

On-demand webinar: The biosimilar breakthrough in adoption and affordability

Lab technician with blue gloves holding a vial
Sort by:
Close search filters
info
Changing filters will change the listed Success Criteria and Techniques
Search results (334)

Type
Topic
Year
Sort by:
Report
Study: Social determinants of health influence breast cancer outcomes
Apr 16, 2025

To better understand how socioeconomic disparities impact breast cancer screening and care, the Evernorth Research Institute analyzed claims data of more than 168,000 women covered by commercial health insurance, Medicaid, or Medicare.

Article
Get the facts: Arkansas Bill HB 1150 puts patients and families at risk
Apr 08, 2025

Here are the facts on what patients could lose if HB 1150 becomes law and eliminates PBM-affiliated pharmacies including retail, specialty and home delivery.

Image
Colorectal Screening
Report
Colorectal cancer screenings at a younger age help lower risk and cost of care
Apr 08, 2025

Screenings can help mitigate the health and cost impact of rising cases among adults under the age of 50.

Image
Evernorth Specialty Spotlight on Jo Stewart, Staff Pharmacist, Freedom Fertility by Evernorth
Article
Special delivery: How a Freedom Fertility pharmacist went above and beyond
Mar 28, 2025

Watch the story of one Freedom Fertility by Evernorth employee’s mission to ensure a patient received her time-sensitive medication.

Image
Blue immune cells attack red cancer cell with magnified view showing antibody binding interaction
Report
Immune checkpoint inhibitor medications: A game-changer in cancer treatments
Mar 27, 2025

A report from the Evernorth Research Institute offers insights that can help health plans optimize cancer care.

Image
Blue-capped vials on a conveyor belt in a sterile pharmaceutical manufacturing facility
Article
Specialty pipeline perspectives: The upcoming wave of biosimilars
Mar 26, 2025

Evernorth anticipates a dramatic shift in inflammatory and oncology treatments over the next five years, with dozens of biosimilars in the pipeline.

Stay up to date on the latest news and insights from Evernorth.

Sign up to receive our monthly newsletter.
woman with kid cropped